Emme Esse Becomes a New synbrAIn Shareholder
In recent years, synbrAIn has made significant strides in the field of Digital Healthcare, developing numerous AI and machine learning-driven solutions to support... Read more.
synbrAIn Acquires SenticLab
After four years of continuous collaboration, synbrAIn has acquired one of its key business partners: SenticLab. Founded in April 2017 in Iași, Northeastern Romania,... Read more.
Major Achievement for SenticLab in the MIA-COV19D Competition at ICCV 2021
MIA-COV19D is an international competition organized by the University of Lincoln (UK), aimed at developing new solutions for identifying COVID-19-related diseases... Read more.
synbrAIn Announces New Strategic Partnership with EMME ESSE
As we announced a few weeks ago, the launch of MS humanAId by Emme Esse has seen synbrAIn’s active involvement in developing a system that leverages artificial... Read more.
MS HUMANAID Now Operational in More Hospitals Across Brianza
The non-profit organization Cancro Primo Aiuto has acquired the MS humanAId platform, developed by EMME ESSE, a synbrAIn partner, to donate it to ASST Brianza, enabling... Read more.
SenticLab, synbrAIn’s Research Partner, Develops a Solution to Identify Tuberculosis Types from Radiographic Images
ImageCLEF is an international initiative organized by the CLEF initiative lab, aimed at fostering the development of new AI and machine learning-based solutions... Read more.
MS HUMANAID: Artificial Intelligence Supporting COVID-19 Diagnosis
Among the various collaborations initiated by synbrAIn, one stands out as particularly significant in the healthcare sector: its partnership with Emme Esse. Emme... Read more.
synbrAIn Continues Its Growth!
synbrAIn was born in 2019 from the merger of GetLeads and Arcaspark. Since then, the company has been experiencing constant growth in terms of personnel, know-how,... Read more.
SenticLab Achieves a Milestone at NODE21 for Lung Cancer Detection
Lung cancer is a severe disease that leads to a high number of fatalities. Among all types of cancer, it is the leading cause of cancer-related deaths worldwide.... Read more.
COVID-X to Fund a New synbrAIn Project
As part of its ongoing commitment to innovation, the synbrAIn team has launched AIDE-X, an acronym for Artificial Intelligence for Early Detection of Lung Diseases... Read more.